Simplex Trading’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-1,307
| Closed | -$6.05M | – | 8312 |
|
|
2019
Q2 | $6.05M | Sell |
1,307
-1,088
| -45% | -$30.5K | 0.02% | 586 |
|
|
2019
Q1 | $5.84M | Buy |
2,395
+1,578
| +193% | +$32.9K | 0.02% | 595 |
|
|
2018
Q4 | $1.16M | Sell |
817
-176
| -18% | -$2.67K | ﹤0.01% | 1511 |
|
|
2018
Q3 | $1.51M | Buy |
993
+325
| +49% | +$4.98K | ﹤0.01% | 1488 |
|
|
2018
Q2 | $1.12M | Buy |
668
+171
| +34% | +$2.72K | ﹤0.01% | 1691 |
|
|
2018
Q1 | $106K | Sell |
497
-274
| -36% | -$4.39K | ﹤0.01% | 1764 |
|
|
2017
Q4 | $154K | Buy |
771
+60
| +8% | +$682 | 0.01% | 1485 |
|
|
2017
Q3 | $170K | Buy |
711
+397
| +126% | +$3.69K | 0.01% | 1310 |
|
|
2017
Q2 | $4K | Sell |
314
-169
| -35% | -$1.38K | ﹤0.01% | 4865 |
|
|
2017
Q1 | $29K | Sell |
483
-450
| -48% | -$4.79K | ﹤0.01% | 2889 |
|
|
2016
Q4 | $198K | Buy |
933
+101
| +12% | +$743 | 0.01% | 1063 |
|
|
2016
Q3 | $112K | Buy |
832
+499
| +150% | +$1.93K | 0.01% | 1447 |
|
|
2016
Q2 | $21K | Sell |
333
-541
| -62% | -$1.76K | ﹤0.01% | 2866 |
|
|
2016
Q1 | $18K | Sell |
874
-7
| -0.8% | -$21 | ﹤0.01% | 2922 |
|
|
2015
Q4 | $26K | Sell |
881
-757
| -46% | -$3.46K | ﹤0.01% | 2489 |
|
|
2015
Q3 | $133K | Buy |
1,638
+1,503
| +1,113% | +$8.91K | 0.01% | 1191 |
|
|
2015
Q2 | $37K | Buy |
135
+118
| +694% | +$871 | ﹤0.01% | 1941 |
|
|
2015
Q1 | $3K | Buy |
17
+7
| +70% | +$50 | ﹤0.01% | 3967 |
|
|
2014
Q4 | $2K | Buy |
+10
| New | +$40 | ﹤0.01% | 3892 |
|
Other funds holding ARRY
Simplex Trading's ARRY Position: Q3 2019 in Review
Simplex Trading sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 13,080 shares — an estimated $605K sold.
Simplex Trading first reported a position in ARRY in Q4 2014 and held it in 10 quarters. The position peaked at $639K in Q2 2018. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.
- Simplex Trading reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
- Simplex Trading sold 13,080 Array Biopharma Inc shares in Q3 2019, an estimated $605K.
- Simplex Trading first reported a position in Array Biopharma Inc in Q4 2014 and held it in 10 quarters.
- Simplex Trading's Array Biopharma Inc position peaked at $639K in Q2 2018.
- 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.
Based on Simplex Trading's 13F filing for Q3 2019, filed 15 Oct 2019.